This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation Protein Therapeutics Summit

$700 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
September 28-30, 2022
Boston Convention and Exhibition Center

Daniel Steiner, Ph.D.
SVP, Oncology Research at Molecular Partners


Daniel Steiner is SVP Research of Molecular Partners. In his previous role with Molecular Partners, Daniel built the department responsible for DARPin generation for all research pipeline projects, specifically establishing the DARPin platform for systemic PK-extension. While earning his Ph.D. at the University of Zurich under Prof Andreas Plückthun, Daniel established a novel in vitro selection system enabling the efficient selection of DARPins for complex antigens. In addition to his doctorate studies at University of Zurich, Daniel performed his undergraduate studies at the ETH Zürich and at the Imperial College London.

Agenda Sessions

  • KEYNOTE: Ensovibep, a clinical stage DARPin Therapeutic for SARS-CoV-2